squalamine has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, JY; Barbut, D; Bienenstock, J; Delungahawatta, T; Diwakarla, S; Farhin, S; Furness, JB; Kunze, WA; Mao, YK; McQuade, RM; Pustovit, R; Stanisz, AM; West, CL; Zasloff, M | 1 |
| Andrieu, V; Brégeon, F; Brunel, JM; Hraiech, S; Lepidi, H; Papazian, L; Raoult, D; Roch, A; Rolain, JM | 1 |
| Blake, DA; Farahat, HG; Genaidy, M; Holroyd, KJ; Kazi, AA; Passos-Machado, E; Peyman, GA; Williams, JI | 1 |
| Ciulla, TA; Criswell, MH; Danis, RP; Holroyd, KJ; McLane, MP; Williams, JI | 1 |
| Geng, Y; Higgins, RD; Williams, JI; Yan, Y; Zasloff, M | 1 |
| Higgins, RD; Sanders, RJ; Williams, JI; Yan, Y; Zasloff, M | 1 |
| Li, D; Pietras, RJ; Williams, JI | 1 |
7 other study(ies) available for squalamine and Disease Models, Animal
| Article | Year |
|---|---|
Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Cholestanols; Constipation; Disease Models, Animal; Electrophysiological Phenomena; Enteric Nervous System; Gastrointestinal Motility; Jejunum; Mice; Mice, Transgenic; Mutant Proteins; Myenteric Plexus; Neurons, Afferent; Parkinson Disease; Patch-Clamp Techniques; Vagus Nerve | 2020 |
Antibacterial efficacy of inhaled squalamine in a rat model of chronic Pseudomonas aeruginosa pneumonia.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Bacterial Load; Cholestanols; Chronic Disease; Colistin; Disease Models, Animal; Lung; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2012 |
Effect of squalamine on iris neovascularization in monkeys.
Topics: Angiogenesis Inhibitors; Animals; Cholestanols; Disease Models, Animal; Fluorescein Angiography; Infusions, Intravenous; Injections; Iris; Laser Coagulation; Macaca fascicularis; Neovascularization, Pathologic; Retinal Vein; Retinal Vein Occlusion; Vitreous Body | 2002 |
Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Cholestanols; Choroid; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Injections, Intraperitoneal; Laser Coagulation; Male; Rats; Rats, Inbred BN | 2003 |
Regression of retinopathy by squalamine in a mouse model.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Cholestanols; Disease Models, Animal; Female; Humans; Infant, Newborn; Mice; Mice, Inbred C57BL; Retinal Vessels; Retinopathy of Prematurity; Time Factors | 2004 |
Squalamine improves retinal neovascularization.
Topics: Animals; Cholestanols; Disease Models, Animal; Fluorescein Angiography; Injections, Subcutaneous; Mice; Mice, Inbred C57BL; Organ Size; Retinal Neovascularization; Retinal Vessels | 2000 |
Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Cell Division; Cholestanols; Cisplatin; Disease Models, Animal; Endothelial Growth Factors; Enzyme Activation; Female; Gene Expression; Humans; Lymphokines; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; Neovascularization, Pathologic; Ovarian Neoplasms; Receptor, ErbB-2; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |